Drug-Coated Balloon for Acute Myocardial Infarction: A Meta-Analysis of Randomized Clinical Trials

Our research hypothesis that DCB might be a feasible interventional strategy in treatment of patients with Acute Myocardial Infarction (AMI).
Our data shows that DCB might be a feasible interventional strategy versus control as it associated with comparable clinical outcomes in the treatment of AMI. Future large-volume, well-designed randomized controlled trials to evaluating the role of the DCB in this setting are warranted.
All data in this research, including major adverse cardiac events (MACEs); target lesion revascularization (TLR); myocardial infarction (MI); cardiovascular mortality; all-cause mortality; stent thrombosis; minimum lumen diameter (MLD) and late lumen loss (LLL), was come from other articles. You can get those data through this research or the articles which this research included.

本研究之假设为，冠状动脉药物球囊扩张术（DCB）或许可作为治疗急性心肌梗死（AMI）患者的一项切实可行的干预策略。据本研究数据揭示，DCB与对照疗法相比，在治疗AMI方面，其临床疗效可与之相媲美。因此，有必要进行大量、精心设计的随机对照试验，以评估DCB在此类情况下的作用。本研究中的所有数据，包括主要不良心血管事件（MACEs）、靶病变血运重建（TLR）、心肌梗死（MI）、心血管病死亡率、全因死亡率、支架内血栓形成、最小腔径（MLD）及晚期腔径丢失（LLL），均源自其他文献。您可通过本研究或本研究所包含的文献获取这些数据。